Studies on the transmission of anti-tumor activity by tumor sensitized ribonucleic acid by Swett, Richard Beckman
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1967
Studies on the transmission of anti-tumor activity
by tumor sensitized ribonucleic acid
Richard Beckman Swett
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Swett, Richard Beckman, "Studies on the transmission of anti-tumor activity by tumor sensitized ribonucleic acid" (1967). Yale
Medicine Thesis Digital Library. 3226.
http://elischolar.library.yale.edu/ymtdl/3226

YALE 
MEDICAL LIBRARY 

i 
) 
STUDIES ON THE TRANSMISSION OF ANTITUMOR ACTIVITY 
BY TUMOR SENSITIZED RIBONUCLEIC ACID 
Richard Beckman Swett, A. B. 
Presented to the Faculty of Medicine, 
Yale University School of Medicine, in Partial 
Fulfillment of the Requirements for the Degree 
of Doctor of Medicine 
Department of Surgery 
April, 1967 
( SEP196fi J 
‘/BRARY-/ 
~Tjj3 
yix. 
<3l?SC> 
Acknowledgements 
I would like to gratefully acknowledge the assist¬ 
ance and support I received from Dr. Richard E. Wilson, 
whose ideas and criticisms led me to a deeper understanding 
of the problems involved, and in whose laboratory this work 
was performed. Dr. W. W. L. Glenn also provided helpful 
counsel. Also, I thank Dr. Frank Stuart for his pertinent 
advice, Miss Katherine Hammock and Miss Ann O'Connor for 
their suggestions and aid, and Miss Elizabeth Watson for 
her enthusiastic technical assistance. 
The work described herein was carried out in the 
Laboratory for Surgical Research of the Peter Bent Brigham 
Hospital and the Harvard Medical School, Boston, Massachusetts. 
Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/studiesontransmiOOswet 
Table of Contents 
Introduction.P 1 
Materials and Methods.P 6 
Results. ..P 17 
Discussion.P 27 
Conclusions.P 39 

-1- 
Introduction 
The concepts of tumor immunity are, at present, not 
clearly defined. The presence of antibodies to some types 
of tumors have been demonstrated, and circulating anti¬ 
tumor antibodies have been identified in the serum of human 
cancer patients by Graham and Graham-*- and by Blakemore and 
McKenna2. Finney, et al.3, have also detected circulating 
antitumor antibodies in humans, a rise in titer occurring 
when those patients were immunized with a homogenate of 
their own tumor. Concentrated plasma globulin from these 
patients was found to be cytotoxic to autologous tumor 
cells. 
The significance of circulating antitumor anti¬ 
bodies and their exact role in tumor immunity is not easy 
to evaluate. Finney correlated rises in antibody titer 
with slight but objective improvement in the course of the 
patients' disease in some cases. Blakemore and McKenna2 
and Graham and Graham-*- felt the presence of antitumor 
antibody had no real demonstrable oncolytic effect. Many 
investigators have demonstrated that heterologous antisera 
have a cytolytic effect on tumor cells4? 5, 6, and 
Bjorklund? developed heterologous antisera in horses that 
were cytotoxic to a number of human cancer cells, but not 
to normal cells. However, antitumor serum has not proved 
. 
. 
* 
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helpful in most clinical trials. 
In animal systems, the study of carcinogen-induced 
tumors^>9jl0? viral-induced tumors-*-^-and spontaneously 
occurring tumors-*-^ ,14,15 has led to substantial evidence 
for the existence of antitumor antibodies. Pilch and 
Riggins1^ found that these antibodies specifically adhered 
to tumor tissue, and that the presence of these antibodies 
was correlated with increased host resistance to isologous 
tumor transplants. 
Experiments with animals have also revealed that 
homologous "sensitized" lymphoid cells possess antitumor 
activity. Woodruff and Symes-*-^ first showed this when they 
found that the growth of a transplanted mammary carcinoma 
in A-strain mice was greatly retarded, and the tumor was 
sometimes completely destroyed, by exposing the recipient 
to a sublethal dose of irradiation (capable itself of 
producing only a very slight effect on the tumor) and then 
injecting allogenic lymphoid cells from a CBA mouse immun¬ 
ized against the A-strain tumor. These procedures did not 
increase (in fact, sometimes decreased) the mean survival 
time of the tumor-bearing animals because those which were 
not killed by their tumor died as a result of the graft- 
vs-host reaction. Using a slightly different system, 
Woodruff, et al.,1'7 showed that the growth of a Landschutz 
tumor was significantly delayed and the survival of the 
. .. ■ 
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animals with the tumor prolonged, by injection of a large 
number of immune rat spleen cells. This was true both 
with and without irradiation of the host, but, after 
irradiation, fewer immune cells were required to produce 
the effect. Host reaction to the heterologous cells was 
a difficulty and attempts to irradicate the tumor com¬ 
pletely produced death from graft-vs-host disease. 
Spleen cell suspensions contain a variety of cell 
types including lymphocytes, plasma cells, and macrophages 
Further information on the specific cell type responsible 
for the observed antitumor effect was obtained by Woodruff 
et al.,1^ using a suspension of thoracic duct lymphocytes. 
They showed that, when compared with sensitized spleen 
cells, sensitized duct lymphocytes were much more damaging 
to the Landschutz tumor and were less prone to cause fatal 
graft-vs-host disease. However, mortality from graft-vs- 
host disease was still a major problem. 
By 1963, occurrence in many cases of specific anti¬ 
tumor antibodies and the effect of "immune" lymphoid cells 
on experimental tumor systems had been well established. 
The major impediment to the use of these antitumor effects 
to produce regression or destruction of tumors was that 
homogenous or heterogenous serum or cells were required. 
The ability to transmit immunity without transmitting 
homogenous or heterogenous identity was sought. 
. 
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One encouraging possibility was the transmission 
of immune potential via ribonucleic acid fractions extracted 
from immune cells. The series of experiments which inspired 
the work presented in this paper were performed by Mannick 
and Egdahl. Their initial work1^ showed that normal rabbit 
lymph node cells could be transformed to a state of trans¬ 
plantation immunity by incubating them in vitro with RNA 
extracted from the cells of an immunized rabbit of the same 
species. The assay of transplantation immunity used in 
these experiments was the transfer reaction of Brent, et 
al.2^, which is a delayed inflammatory reaction in the skin 
produced by intradermal injection of specific immune cells. 
These findings were confirmed by Clarke and Wilson21 and by 
Najarian22. Subsequently Mannick2^ and Mannick and Egdahl24 
demonstrated that this technique could be applied directly 
to the study of transplantation immunity, for they deter¬ 
mined that heightened immunity to skin homografts could be 
transferred from one animal to another by RNA extracted 
from sensitized lymph nodes. These experiments gave in¬ 
direct evidence that RNA had the ability to transfer to 
previously uninstructed cells a template for the synthesis 
of cell-bound antibody, which presumably is responsible 
for transplantation immunity. 
With this evidence of the presence of both serum 
and cellular antitumor immune activity, and the demonstration 
■ 
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-5- 
by Mannick and Egdahl of the transferance of transplanta¬ 
tion immunity via in vitro incubation of lymphoid cells 
with ’’immune RNA”, it was decided to attempt to apply their 
techniques to tumor immunity problems. The great advantage 
of these techniques was that they might avoid the graft-vs- 
host reaction encountered with the use of heterogenous 
cells or serum. One could transplant a tumor to a heter¬ 
ologous host, harvest the immune lymphoid cells, extract 
the RNA, and incubate it in vitro with isologous lymphoid 
cells, which then could be returned to the isologous tumor- 
bearing host. Thus, one could avoid the graft-vs-host 
reaction against heterologous cells, and yet transmit to 
the isologous cells, by incubation with the sensitized RNA, 
the information necessary for the production of antitumor 
activity. Since any heterologous RNA incorporated into 
the isologous lymphoid cells would also probably provide 
information for the production of other (heterologous) 
proteins as well as tumor-specific antibodies, all graft- 
vs-host reactions might not be prevented, but it seemed 
reasonable to assume they would be minor. 
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Materials and Methods 
General Protocol: The present experiments are divided into 
two interrelated groups. The basic experimental plan was 
to use mice as the tumor host and rabbits as the hetero¬ 
genous acceptors of mouse tumor cells and the source of the 
immune RNA. The DBA-2 mouse and L1210 ascites tumor were 
chosen, because an easily reproducible survival time was 
produced by this combination. Ascitic tumor fluid was re¬ 
moved from stock tumor bearing mice and injected into the 
foot pads of rabbits, who then ’’rejected" the tumor. The 
rabbit lymph nodes draining the tumor injection site were 
then excised, and the RNA extracted from them. The RNA 
was measured quantitatively and assayed for DNA and pro¬ 
tein contamination, and was incubated with isologous mouse 
spleen cells. These cells were then counted and injected 
intraperitoneally into tumor-bearing mice. The mice were 
weighed daily, and both the weight curves and survival 
times recorded. The appropriate injections of control 
cells (one cell suspension incubated with normal rabbit 
RNA; and another cell suspension incubated with RNA 
"sensitized" to normal mouse spleen cells and skin grafts) 
were included. 
The second group of experiments were undertaken to 
determine whether, under the conditions used, any of the 
-■£ 
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RNA was being taken up into the cells during incubation. 
Rabbits were injected intravenously with C-^-labeled adenine 
and the specific activity versus time curve of the RNA-C^4 
extracted from the popliteal lymph nodes was determined. 
After the point of maximum labeling efficiency was deter¬ 
mined, C^^-labeled RNA was extracted, quantitatively 
measured, and incubated with normal DBA-2 mouse spleen 
cells. The incubated cells were then measured for incor¬ 
porated radioactivity by means of liquid scintillation 
techniques. 
Animals: All mice used (normal spleen cell and skin donors, 
L1210 donors, and L1210 plus treatment recipients) were 
DBA-2 strain females weighing initially 15 to 25 grams. 
(Jackson Laboratories, Bar Harbor, Maine). All rabbits 
used were white New Zealand females, averaging 2 to 3 kilo¬ 
gram in weight. 
Preparation of Normal DBA-2 Spleen Cell Suspensions: DBA-2 
mice were killed by traumatic cervical dislocation, and the 
spleen quickly removed. The spleens were sliced into small 
chunks, placed in 5 ml. of ice-cold Hank's solution, and 
then passed through screens of #60 (0.307mm) and #200 mesh 
(0.086mm). Cell counts were performed using a standard 
hemocytometer chamber, and viability determined using the 
eosin dye exclusion method. Cell concentrations were 
adjusted as necessary by centrifuging ice-cold cell suspen¬ 
sions in Hank's solution for five minutes at 1,000 Xg 
'■ 
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(International Clinical Centrifuge - Model CL), and re¬ 
suspending the cell-button in the required amount of ice- 
cold Hank's solution. 
Harvesting of L1210 Ascitic Fluid: A DBA-2 mouse carrying 
L1210 tumor (courtesy of Children's Cancer Research Founda¬ 
tion, Boston, Massachusetts), which had progressed to the 
stage of marked abdominal distention, was killed by traumatic 
cervical dislocation. The mouse was quickly dipped in one 
per cent Lysol solution, and the abdominal skin incised, 
with the peritoneum left intact. A sterile 20-gauge needle 
was introduced through the peritoneum, and ascitic fluid 
containing tumor cells withdrawn. The fluid was diluted 
1:12.5 with cold Locke's solution, and cell count and 
eosin viability determination performed. When L1210 tumor 
cells were injected into the foot pads of rabbits, undiluted 
ascitic fluid was used. 
Application of Mouse Skin Grafts to Rabbits: DBA-2 mice 
were anesthetized by intraperitoneal injection of nembutal 
solution. The abdomen was shaved, two 2x2 cm. patches 
of full-thickness skin were removed from it, and a patch 
placed over an area on the lateral side of each lower 
extremity of a rabbit which had been shaved and had a 
corresponding 2x2 cm. full thickness skin patch removed. 
Eight 5-0 silk sutures were used to secure the grafts, 
which were then each covered with a sterile dressing and 
a plaster cast. 
■ 
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Harvesting of Rabbit Lymph Nodes and Preparation of Lymph 
Node Cell Suspensions: The rabbits were sacrificed by 
administration of a fatal dose of nembutal solution intra¬ 
venously. The popliteal nodes were removed from each leg 
and in some control rabbits, the mesenteric nodes were 
removed by laparotomy. Adherent fat was removed from the 
nodes, which were then minced finely in ice-cold Hank's 
solution. The suspension was passed through one layer of 
double-napped flannelette and a cell count and aneosin 
viahility test were performed on the resulting cell 
suspension. 
Preparation of RNA from Rabbit Lymph Nodes:Fresh 
rabbit popliteal or mesenteric nodes were placed in ice- 
cold normal saline, and the adherent fat removed. All 
further operations were carried out in a cold room at 5° 
Centigrade. The lymph nodes were homogenized with 15 cc. 
citrate buffered saline (0.14 M NaCl, 0.01 M citrate), 
and the homogenate centrifuged for 15 minutes at 3>000 Xg. 
The supernatant was shaken three times with equal volumes 
of cold, water-saturated phenol, separation being obtained 
by centrifuging the mixture for five minutes at 3,000 Xg. 
The aqueous layer from these extractions was extracted 
five times with equal volumes of cold absolute ether, and 
the dissolved ether blown off the aqueous layer from the 
final extraction using a stream of nitrogen gas. One ml. 
of aqueous layer was removed for purity tests and 
* 
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quantitative analysis of RNA content. The orcinol quanti¬ 
tative analysis for RNA2^ revealed 100-200^ RNA/cc of 
aqueous layer. The Lowry quantitative analysis2^ for 
protein revealed 0-5 ^ protein/ml, and the diaphenylamine 
quantitative analysis for DNA2^ revealed no DNA. Deter¬ 
mination of the ultraviolet absorption spectrum using a 
Zeiss spectrophotometer demonstrated a X maximum at 260 
millimicrons, the same as that described by Mannick2^ for 
his RNA preparation. 
In later experiments, where C14-labeled RNA was 
prepared, a slightly modified technique of RNA extraction 
was used. The popliteal lymph nodes of a rabbit were 
hypertrophied by the injection of 0.5 ml of sheep red blood 
cells into the rear foot pads. Four days later a 0.10 me 
sample of adenine-8-C14, dissolved in 2.0 ml phosphate 
buffer (0.05M phosphate, pH 7.1), was injected intravenously 
into the ear vein of the rabbit. After a preset interval 
the rabbit was sacrificed, and the popliteal and mesenteric 
nodes removed. The lymph nodes were homogenized for five 
minutes in the cold with 8 ml of water-saturated phenol 
and 8 ml of EDTA-phosphate buffer (0.05 M phosphate, 0.01 
M EDTA, pH 7.1), using an electric homogenizer. The 
homogenate was centrifuged in the cold for ten minutes 
at 3,000 Xg and the aqueous layer removed. The aqueous 
layer was shaken with 10 ml of cold, water-saturated phenol, 
centrifuged again for ten minutes at 3,000 Xg, and the 

-11- 
aqueous layer removed. The aqueous layer was extracted 
five times with an equal volume of cold ether, and the 
ether was blown off using a stream of nitrogen gas. Two 
volumes of absolute ethanol were added, and the solution 
allowed to cool at 5° C for forty-five minutes. The pre¬ 
cipitated RNA was collected by centrifuging the solution 
in the cold for five minutes at 1,000 Xg. The RNA was 
resuspended in 1 to 2 ml of phosphate-EDTA buffer, placed 
in dialysis tubing^ and dialyzed for one hour against 
phosphate buffer without EDTA. The resulting RNA solution 
was quantitatively tested for RNA, DNA, and protein, as 
before. Tests for DNA and proteins revealed the same low 
levels of these materials, and the ultraviolet absorption 
curve was characteristic of RNA. This method resulted in 
a yield of 1,000 to 1,5000 of RNA/ml. An aliquot was 
removed for C14 specific activity determination. 
Incubation of Spleen Cells with RNA:^3 Spleen cell suspen¬ 
sions were centrifuged in the cold at 500 Xg for five minutes. 
The supernatant was poured off, and the cells resuspended by 
addition of equal volumes (8 to 10 ml) of RNA solution and 
1.4 M sucrose solution. After gentle mixing, the samples 
were incubated for 15 minutes at 37° C in a water bath with 
frequent shaking. After incubation, the solution was flooded 
with one volume of cold Hank's solution, recentrifuged as 
before, and then suspended in 6.5 ml of cold Hank's solution. 
The resulting solutions had a cellular viability of 80 to 
'• 
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95 per cent and contained an average of 1 x 10-7 viable 
cells/ml. In some incubations, Eagle’s medium replaced 
Hank's solution and»osome polyvinylpyrrolidone or dextrose 
was added to increase the osmolarity of the solution. 
Scintillation Counting of C-^-Labeled Ma28,29; To a 
measured volume of RNA-C^ solution was added an equal 
volume of 5 per cent trichloroacetic acid. The solution 
was mixed, and then heated in a water bath at 90° C for 
thirty minutes. The clear digest thus produced was added 
oQ 
to 10 ml of Bray's solution1^0 in a scintillation counting 
vial, and counted for ten minutes in a Nuclear-Chicago 
Multiple Sample Scintillation Counter. Blanks of the 
various "solvents" were counted in the same manner for 
controls. The counting efficiency of the counter for C14 
was determined to be 75 per cent using an adenine-S-C-1^ 
internal standard. 
Scintillation Counting of Cells: Normal Cells, and Cells 
after Incubation with C-^-RNA"1®? Two different methods 
were used to measure the radioactive content of normal 
(control) spleen cells and normal cells that had been incu¬ 
bated with C14-labeled RNA. The results from a series using 
each method are reported. 
The method used initially consisted of mixing directly 
0.5 ml of the cell suspension with approximately 10 ml of 
Bray's solution contained in a counting vial. The solutions 
were counted in a Nuclear-Chicago Multiple Sample Scintillation 
' 
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Counter, This method had the advantage of simplicity, but 
it also had the disadvantage of not separating labeled 
nucleotides and nucleosides from the labeled nucleic acid. 
Therefore, this assay was valuable only for indicating if 
C^, in any form, crossed the cell membrane during 
incubation. 
The second method resulted in the separation of 
nucleic acids, phospholipids, and proteins, from the other 
cell components (including soluble nucleotides and nucle¬ 
osides). This permitted separate counting of these two 
cell-component aggregates.* To a measured volume (approxl 
mately 1.0 ml) of cell suspension, containing a known 
number of cells, was added 1.0 ml of cold 20 per cent 
trichloroacetic acid. This suspension was mixed, centri¬ 
fuged in the cold at 1,000 Xg for ten minutes, and the 
supernatant removed and saved (this contained all cell 
components other than nucleic acids, phospholipids, and 
proteins). To the precipitate was added 1.0 ml of cold 
10 per cent trichloroacetic acid, and this was shaken well 
and centrifuged in the cold at 1,000 Xg for ten minutes. 
The supernatant was removed and combined with the super- 
natent from the previous step. To the precipitate was 
added 1.0 ml of 5 per cent trichloroacetic acid, and the 
* Developed in cooperation with Dr. S. James Adelstein, 
Department of Radiology, Peter Bent Brigham Hospital, 
Boston, Massachusetts. 
. 
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mixture was heated in a 90° C waterbath for thirty minutes. 
This digest was centrifuged at 1,000 Xg for ten minutes, 
and the supernatant removed. To the precipitate was added 
1.0 ml of 5 per cent trichloroacetic acid, and the mixture 
was heated in a 90° C waterbath for thirty minutes. The 
digest was then centrifuged at 1,000 Xg for ten minutes, 
the supernatant combined with that from the preceeding step, 
and the precipitate saved. One ml of cold wash supernatant 
and one ml of the digest supernatant were added to separate 
counting vials containing Bray's solution. The remaining 
precipitate was resuspended in 10 ml of Bray's solution in 
a counting vial. All samples were counted for ten minutes 
in a Nuclear-Chicago Multiple Sample Liquid Scintillation 
Counter. Appropriate blanks were also processed as above 
and counted. 
Inl Vivo Assay for Antitumor Effects Transferred via 
Sensitized RNA: Three rabbits and forty eight mice were 
used for each experimental trial. One rabbit received full 
thickness mouse skin grafts on each hind leg and approxi¬ 
mately 1 x 10?DBA-2 mouse spleen cells into the foot pad 
Q 
of each hind leg. One rabbit received approximately 1 x 10 
L1210 tumor cells into the foot pad of each hind leg. One 
rabbit was untreated. Forty-eight DBA-2 mice were used for 
each experiment, and these were divided into three main 
groups (I, II, III). Each mouse received approximately 
1 x 10^ live L1210 cells by intraperitoneal injection - 
' 
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Group I, one day prior to the treatment of some of the 
mice with RNA-incubated cells, Group II, on the day of 
such treatment, and Group III, one day after. Each of 
these three groups was divided into four subgroups (a, 
b, c, and d) as follows: Subgroup a (treatment group) 
received L1210 cells plus approximately 5 x 10^ live 
spleen cells which had been incubated with RNA from a 
rabbit sensitized to L1210 cells; subgroup b (control 
group) received the L1210 cells plus an intraperitoneal 
injection of approximately 5 x 10 live spleen cells 
which had been incubated with RNA from rabbits sensitized 
to DBA-2 spleen cells and skin grafts; subgroup c (con¬ 
trol group) received the L1210 cells plus the intraperi¬ 
toneal injection of approximately 5 x 10^ live spleen 
cells which had been incubated with RNA from a normal 
rabbit; and subgroup d (basic control) received the L1210 
cells only. The basic protocol is outlined in Table 1. 
After the completion of the L1210 cell and RNA-incubated 
cell injections, the mice were weighed each day, and the 
survival time recorded. 
' 
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Results 
In Vivo Assay 
The in vivo assay was repeated four times. In all 
experiments, the weight curves were of identical shape for 
both the treated and untreated groups. The initial portion 
of the curve rose steadily, which indicated the expected 
growth rate of the young mice. This weight gain continued 
after the injection of L1210 and treated cells, until six 
to eight days after the tumor injection when the weights 
began to drop steadily, due to the effects of the tumor 
metabolism. The symmetry of the curves for both treated 
and control groups, plus the lack of any indication of de¬ 
crease or delay in weight loss in the treated groups, 
indicates the lack of effect of the treated cells. There 
was also no significant difference in the weight curves of 
the untreated mice and those of the mice treated with cells 
that had been incubated with normal rabbit RNA or RNA from 
rabbits sensitized specifically to mouse tissue, thus in¬ 
dicating the lack of any generalized graft-vs-host or 
Mrunting"effeet. 
The mean survival times for each subgroup, as well 
as for each group as a whole and each trial, are expressed 
in Table II. The standard error limits for each of these 
averages are also expressed. The data illustrate that the 
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mean survival times for all subgroups became longer as 
the experiment was repeated. This was expected because 
when the first experiment demonstrated that the treated 
cells were not prolonging mean survival time the dose of 
L1210 cells injected into the mice was reduced in an 
attempt to accentuate any antitumor effect present. It 
is also obvious that even within a single experiment the 
average mouse lifespan in all subgroups varied somewhat 
depending on what day the L121Q cells were injected in rela¬ 
tion to the day of injection of the treated cells. This 
also is not unexpected, for each day's supply of tumor was 
either from a different mouse source or of a slightly 
different age, so although the number of viable cells in**) 
jected in each group within an experiment was nearly equal, 
the destructive effect of these inocula was not exactly 
equal. The most important fact is that in no case was 
the average lifespan of the mice treated with spleen cells 
incubated with "tumor-sensitized" RNA significantly longer 
than the average lifespan in any of the control subgroups. 
This was true regardless of the time the RNA-treated cells 
were administered in relation to the time of tumor injec¬ 
tion. Also, mean survival times were not significantly 
different from subgroup to subgroup, indicating the anti¬ 
tumor treatment and the various control treatments had no 
significantly different effect. 
Determination of the Most Efficient Method of In Vivo 
■' 
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Preparation of RNA-cJ^: 
As described above, C^-labeled adenine was injected 
intravenously into normal rabbits whose popliteal lymph 
nodes had been stimulated by injections of normal DBA-2 
mouse spleen cells four days previously. The nodes were 
then harvested at different times. A small aliquot of cell 
suspension was saved for direct counting, and the remainder 
of the cells were used as a source of RNA-C^4'. Figure I 
shows the relationship of the specific activity of this 
RNA-C-1-4' to the period of time between adenine-8-0^ injec¬ 
tion and rabbit sacrifice. The line representing the 
specific activity of the extracted RNA-C^ shows that the 
specific activity begins to rise sharply about nine hours 
after the injection of the adenine-8-C14, reaching a peak 
at about fifteen hours, and then falling sharply again. 
In order to determine into what cell components the 
RNA-C-1-4" was being incorporated, samples of the labeled 
cells were extracted with cold and hot trichloroacetic 
acid. The hot trichloroacetic acid extract contained the 
activity from nucleic acids, phospholipids, and proteins 
and the cold trichloroacetic acid extract contained the 
activity from all other cell contents. Two lines were 
plotted using this data; one representing the counts/ 
cell/minute of the hot trichloroacetic acid extract vs. 
time; and another representing the total counts/cell/ 
minute of Cactivity (the sum of the activity of the 
• 
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cold trichloroacetic acid extract, hot trichloroacetic 
acid extract, and any remaining precipitate). The graph 
demonstrates that the activities versus time curves of 
the two extracts were of identical shape, with the total 
activity being only slightly greater than the activity of 
the hot trichloroacetic acid extract. Since none of the 
from adenine-8-C^4 should be present in either the 
phospholipids or protein components of the hot trichloro¬ 
acetic acid extract, these results indicate that nearly 
all (88 to 92 per cent) of the activity was present 
in the RNA component. The slight additional activity 
(8 to 12 per cent) found in the total extract is most 
likely due to the adenine-8-C14 incorporated into soluble 
nucleotides. Based on the above data, it was felt that 
RNA-C14' could be most efficiently prepared by harvesting 
the rabbit lymphoid tissue about fifteen hours after the 
intravenous injection of the adenine-8-C^. 
Experiments to Determine Whether RNA was Passing into 
Neutral Cells During Incubation 
Two series of experiments, in which normal DBA-2 
mouse spleen cells were incubated with rabbit RNA-C-L4, 
were done to determine whether RNA was passing into neutral 
cells during the incubation step in the "in vivo assay". 
In the first series, the incubated cells were added 
directly to Bray's solution and counted by the liquid 
~<c 
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scintillation method. All incubations were of fifteen 
minutes duration.23 Because Ellem and Colter3°j31 sug¬ 
gested that an increase in the osmolarity of the incuba¬ 
tion medium produces an increase in the uptake of large 
molecules, the osmolarity of the incubation medium was 
varied in some incubations by the addition of polyvinyl- 
pyrolidone or dextrose. The data in these experiments, 
however, as illustrated in Table III, show that no signi¬ 
ficant amount of RNA-C-1-4' was taken up by the cells. This 
was also true when the osmolarity of the incubating medium 
was increased. The average number of counts per minute 
per milliliter of cell solution of both the control and 
incubated cell samples were not significantly different 
from the number of counts per minute per milliliter of 
the Eagle's solution alone (in which both cell suspensions 
were suspended). This is true regardless of the number of 
cells per milliliter of solution within a 100-fold range, 
thus indicating that the radioactivity detected in both 
the control and incubated solutions can be attributed to 
the Eagle's medium alone. 
The second series of incubations were performed in 
the same manner as described above, but the measurement 
of radioactivity was carried out on the final fractions 
of the trichloroacetic acid extraction procedure. The 
data, described in Table IV, revealed that when the average 
counts per cell per minute of control and incubated cells 
' 
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were compared, both the hot trichloroacetic acid extracts 
(measuring RNA-C'L4 counts) and the total extracts (measur¬ 
ing the total C14- activity) showed no significant difference. 
The results of both of the series described above 
indicate that, using the materials, conditions, and pro¬ 
cedures above, no significant amount of RNA passed from the 
incubation medium into the cells. 
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Discussion 
The present results indicate that the in vivo anti¬ 
tumor activity assay does not show antitumor activity com¬ 
parable to the heightened immunity to skin grafts shown by 
Mannick and Egdahl2^?24 in a somewhat similar system. The 
present results also show that no significant amount of 
RNA uptake into the cells occurs using the present materials 
and incubation methods. Since the results of the experi¬ 
ments of Mannick and Egdahl^-9,23,24 are best explained by 
the assumption that "programmed" RNA or an RNA-containing 
complex is taken up by the cells during incubation, and 
that this RNA or RNA-containing complex then subsequently 
stimulates the production of immune activity in the in vivo 
system, the failure of uptake in the present system probably 
explains the failure of proauction of measurable antitumor 
activity in the in vivo assay. The most meaningful way to 
judge the results of the present experiments is to compare 
them with the past work of others. 
The earliest work on the effect of ribonucleic acid 
on intact cells was done by virologists, using viral RNA. 
Alexander, et al.^2, in 1958, reported that poliovirus 
RNA was taken up by human cell monolayers, and that intact 
polio virus could be isolated from these cells. Moloney33 
found that a mouse leukemia which was transferable by a 
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viral agent could also be transmitted by an RNA extract 
of the tumor, and that this transmission could be pre¬ 
vented by the treatment of the RNA extract with ribonu- 
clease. Ellem and Colter3°>31,34 described the kinetics 
of the interaction of infectious viral RNA with a mammalian 
cell line, as measured by both the formation of infectious 
centers and by the measured cell uptake of RNA-P*'2. They 
found that for their system of viral RNA incubated with HeLa 
cells, 1) the maximum infectivity occurred with solutions of 
saline or sucrose in saline when the osmotic pressure was 
4 to 5.8 times that of physiologic saline, 2) maximum in¬ 
fectivity occurred after 6 to 8 minutes of incubation, 
3) maximum infectivity occurred at 37° C, 4) the infectivity 
was directly proportional to the RNA concentration in the 
incubation medium, and 5) a very small amount of RNA was 
taken up by the cells and only a very small percentage of 
the cells were infected. Holland, et al.85J found that 
poliovirus RNA can infect non-primate cells, which are not 
susceptible to infection by the intact poliovirus. Holland, 
et al.36, aiso noted that only a small fraction of the total 
incubated RNA was taken up by the cells, and noted that the 
infectivity was enhanced by hypertonic solutions. 
Experiments in which RNA has been incubated with 
intact viable cells fall into two basic categories: 1) 
those where the uptake of RNA is implied by the resulting 
functional or morphological alterations in the cell systems, 
• ^ 
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and 2) those where the uptake of the RNA has been ’’proven" 
by the demonstration of incorporation of labeled RNA into 
the cells. 
The early work of Niu falls into the first cate¬ 
gory. In 1958) Niu^? showed that treatment with RNA could 
modify embryonic differentiation. In later work, Niu, et 
al.38, aXso demonstrated that the differentiation of mouse 
ascites tumor cells could be increased by incubation with 
RNA from mouse liver cells, that these cells then produced 
more serum albumin-like-proteins than control cells, and 
that formation of an adaptive enzyme could be induced by 
this procedure.39 Similarly, Aksenova, et al.4^, demon¬ 
strated that the capacity of tumor cells for autonomic 
growth decreases after their incubation with RNA from 
normal tissues. This effect showed both organ specificity 
and species specificity. 
Ribonucleic acid extracts can stimulate antibody 
synthesis by cells and this fact implies cell uptake of 
RNA. In 1961, Fishman4-^- demonstrated that the in vitro 
stimulation of rat lymph node cultures with cell-free 
filtrates derive from homogenized rat macrophages which 
had been incubated with T2 bacteriophage caused the appear¬ 
ance of antibody activity against T2 bacteriophage. The 
addition of T2 bacteriophage alone to the cultures did not 
cause the antibody production, nor did antibody produc¬ 
tion occur if ribonuclease was added to the medium. It 
' 
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was also found that macrophages and lymph nodes cells had 
to be obtained from animals of one and the same species. 
The most likely explanation for these results was that the 
cell-free filtrate derived from the macrophages contained 
RNA or complexes of RNA and antigenic fragments. In a 
later experiment, Fishman and Adler , found that the cell- 
free macrophage filtrate could be placed into a millipore 
chamber within the rat, and the same antibody production 
was elicited. They theorized that the filtrate elements 
were taken up by the rat's lymphocytes, which surrounded 
the chamber. The fact that x-irradiation of the host 
abolished the antibody production strengthened this view. 
It was also shown that RNA extracted from the macrophages, 
when placed in the millipore chamber with normal lymphoid 
cells, caused antibody to be present in an x-irradiated 
rat. These experiments indicated that RNA or an RNA- 
antigen complex was the active substance in the cell-free 
macrophage filtrate. 
Friedman4^ has also detected the induction of in 
vitro antibody synthesis by nonimmune spleen cells after 
their exposure to RNA from spleen cells of immunized 
animals of the same species. Mice were sensitized to 
sheep red blood cells, and the RNA was extracted from 
the spleen cells of these animals using the cold phenol 
method. The RNA was incubated at 37° C for thirty minutes 
with normal isologous mouse spleen cells. After washing, 
, 
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the cells were added to an agar medium containing sheep 
red blood cells, and guinea pig complement was added, as 
in the technique described by Jerne, et al.44 Cellular 
antibody production was indicated by plaques of hemolysis 
in the background of sheep red blood cells. In his initial 
work, Friedman4"^ obtained a five to ten times increase in 
the plaque production over control levels, and found that 
the response was specific in that the RNA-incubated cells 
would cause hemolysis of sheep cells only. A later experi¬ 
ment by Friedman4^ confirmed his original work, but also 
showed that the number of plaques formed by the incubated 
cells was only about ten per cent of the number formed by 
plating the immune cells themselves, thus indicating that 
the number of incubated cells effectively taking up RNA 
was small. It was also shown that adding ribonuclease to 
the incubation medium abolished the plaque-producing effect. 
By using the same technique, Friedman4^ showed that some 
species of mice undergo the transfer phenomenon better 
than others, and that spleen cells are better for use in 
the transfer phenomenon than other cells, in the relative 
order: spleen cells > pooled lymph nodes » peripheral 
leukocytes»» thymus, bone marrow, lung, liver, brain, 
kidney, and skeletal muscle. He also showed that both 
peak serum hemolysin titers in the sensitized mice and 
peak plaque production by the incubated cells occurred at 
four days after the mice were injected with sheep red 
blood cells. 
* 
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Friedman and Stavitsky4?, using rat macrophages and 
rat lymph node cells, found that the ability to produce 
neutralizing antibody to T2 bacteriophage could be trans¬ 
ferred, thus confirming the results of Fishman4-1. They 
also found that serologic analysis of the RNA derived from 
the reaction of phage and macrophage contained T2 tail and 
internal protein antigens. This strengthened the hypothesis 
that the active transfer fraction might be an RNA-antigen 
complex as stated by Askonas and Rhodes4®, Campbell and 
G§.rvey49, Garvey and Campbell^, Saha et al.^1, Fishman41, 
Schwarz and Reike^2, and Spiers^®, Cohen and Parks^4 also 
demonstrated antibody production by nonimmune mouse spleen 
cells incubated with RNA from immunized mice. Their proto¬ 
col was quite similar to that of Friedman4®, and the plaque 
technique was used for antibody assay. Their RNA extrac¬ 
tion used a modification of the warm-phenol method used by 
Scherrer and Darnell^ rather than the cold-phenol method 
used by Friedman4®. Cohen and Parks^4 found an average 
of a five-fold increase in plaque production by the incu¬ 
bated cells when compared with control cells, but only a 
small proportion of the incubated cells became antibody 
producing. In a later experiment, Cohen, Newcomb, and 
Crosby^® found that the conversion was partially strain- 
specific. Also, they found that the active material 
resisted digestion by trypsin, pronase, and both c* andp 
amylase, and yet was totally inactivated by ribonuclease 
. 
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in low concentrations. They felt that this indicated that 
RNA was the important component of the active transfer 
material, and that antigen was not important. The experi¬ 
ments of Mannick^3, and Mannick and Egdahl^,2^ described 
earlier in the Introduction, which demonstrated the ability 
of "immune” RNA to transfer both a state of transplantation 
immunity and an heightened immunity to skin homografts, 
were important in the series of experiments which indirectly 
demonstrated the uptake of "immune" RNA into nonimmune cells. 
The work of Amos et al.5/,58 jlas that incuba¬ 
tion of mammalian cells with bacterial RNA causes demon¬ 
strable changes. Amos and Moore^ showed that RNA extracted 
from E.coli and incubated with chick embryo cells advanced 
the initiation of cellular protein synthesis, and Amos and 
Kearnes^? showed that 5 to 15 per cent of the newly synthe¬ 
sized protein could be shown to possess the antigenic 
character of E.coli protein. Amos and Moore^ found that 
the active bacterial RNA resembled m-RNA in its distribution 
in the cell fractions. 
The second category of experiments concerning the 
cellular uptake of RNA is that where the uptake has been 
"proven" by the use of labeled RNA. Niu, et al.38? pre¬ 
pared mouse RNA-C14” and incubated it with mouse ascites 
tumor cells for twenty hours, and the RNA isolated from 
these cells was radioactive. Amos59 incubated cultured 
' '' 
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chick embryo cells with PJ,i“labeled E.coli RNA, and found 
that 1 to 2 per cent of the RNA presented to the cells was 
incorporated, Amos and Kearnes^ felt that the slow uptake 
was due in part to the rapid depolymerization of RNA by 
ribonuclease in the culture medium and from the cells. 
They found that the RNA could be protected from destruc¬ 
tion by any of several polybasic materials: streptomycin, 
spermine, spermidine, protamines, and histones. Protamines 
and histones stimulated uptake of RNA in their system. 
Schwarz and Reike^2 injected mice with tritiated cytidine, 
extracted labeled RNA from liver tissue, and then incubated 
the labeled RNA with normal peritoneal mononuclear cells, 
and with mouse sarcoma cells. Labeled RNA was also injected 
intraperitoneally into normal and sarcoma-bearing mice. 
Radioautography of in vivo and in vitro cell samples from 
both normal and sarcoma bearing mice revealed rapid uptake 
of the label (two hours was the earliest interval examined). 
The label first was maximal over nucleoli and nuclei, and 
later appeared in the cytoplasm. Some radioactivity remained 
in the cells after ribonuclease digestion, and the discrete 
nuclear localization of the label suggested that this repre¬ 
sented incorporation of labeled materials into DNA. Label 
of this type was specifically removed by deoxyribonuclease 
digestion, so Schwarz and Reike concluded that both DNA and 
RNA were labeled by the injected RNA, but that much the 
larger part of the lable appeared as RNA. Fishman, et al. x 
performed a similar experiment, using tritium-labeled RNA 
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produced in rat or rabbit macrophages, extracted by the 
cold-phenol method. The labeled RNA was incubated with 
rat or rabbit lymph node cells (same species as the RNA 
source), and autoradiographic smears of the cells were 
made which showed the presence of radioactive material 
within the cells. One day was the earliest sampling time, 
so it is not known how soon the radioactivity appeared 
within the cells. Fishman and Adler also made the 
interesting observation that when labeled RNA from macro¬ 
phages was added to a lymph node cell culture where 
macrophages were present, '’clones” were seen in which 
lymphocytic cells surrounded a macrophage, and incorpora¬ 
tion of the label occurred in both cell types. Those 
lymphocytes surrounding the macrophages were labeled to 
a greater degree than were the lymphocytes not surrounding 
the macrophages. This suggested transmission of RNA or 
an RNA-antigen complex from macrophages to lymphocytes. 
Schoenberg, et al. , examined spleens and lymph nodes of 
immunized and non-immunized rabbits using light and elec¬ 
tron microscopy. They found that there were some "clones” 
of lymphocytic cells surrounding macrophages, but that 
the majority of lymphocytic cells were not in such an 
arrangement. However, there were more clone arrangements 
in immunized animals than in those not immunized. Electron 
microscopy revealed areas of direct communication between 
the cytoplasm of the macrophages and some of the immediately 
*. 
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adjacent lymphocytic and plasma cells. There were more of 
these cytoplasmic connections in the immunized animals than 
in those not immunized. These connections may be evidence 
for the transfer of cytoplasmic content from macrophages to 
lymphocytic cells. This exchange would be a likely route 
for the transfer of RNA or RNA-antigen complexes. 
In considering the above evidence for the cellular 
uptake of labeled RNA, it is obvious that the presence of 
label within the cell is not necessarily indicative of RNA 
uptake. Even the isolation of labeled RNA from within the 
cell is not proof of the uptake of intact RNA for it would 
be possible for label-containing nucleic acid fragments or 
metabolites to pass into the cell and then be reincorporated 
into RNA. With the present tools, it would indeed be diffi¬ 
cult to prove the form in which the label crosses the cell 
membrane during incubation. Evidence for the presence of 
the label within the cell, however, is good. When this is 
considered along with the various demonstrations of the 
functional and morphological alterations in cells that 
have followed their exposure to intact RNA, the likelihood 
is great that in some systems cellular RNA uptake is 
occurring. If this is true, then why was in vivo anti¬ 
tumor activity or labeled RNA uptake not seen in the 
present experiments? The media, conditions, and duration 
of RNA exposure in the present system were similar to the 
many experiments using both viral and vertebrate RNA which 
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showed uptake of RNA, so the difference in results was 
probably not due to a difference in basic procedure. Upon 
reviewing the present experiment against the background of 
those experiments reported in the literature, the most 
significant difference seems to be that in most of the 
past experiments the cells used as a source of RNA and the 
cells that the RNA was incubated with were always from the 
same species and usually from the same strain, while in 
the present experiment the sources of RNA and incubated 
cells are from different species of animal (i.e., rabbit 
RNA, mouse cells). 
The many cases of uptake of viral RNA by animal 
cells, plus the demonstration by Amos, et al.57,58,59,60^ 
of chick embryo cell uptake of bacterial RNA might lead 
one to think that species differences between the RNA and 
the incubated cells should not be a problem. However, only 
two cases have been reported of attempts to produce the 
uptake of animal RNA into cells of a different species, 
and both of these indicate that uptake is decreased or not 
significant. Askenova, et al.4^, showed that the incuba¬ 
tion of rat liver mucous carcinoma with normal rat liver 
RNA produced a strong inhibition of tumor growth. However, 
when RNA from guinea pig liver was used, the effect was 
weaker, and the authors felt that this might be due to 
species specificity. The most convincing data on this 
* ' 
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problem is that of Fishman4^, who found that antibody 
production by rat lymph node cells against T2 phage could 
be induced by the incubation of the normal rat lymph node 
cells with a cell-free filtrate of rat macrophages which 
had been exposed to T2 antigen. However, when filtrates 
were prepared from rabbit or HeLa macrophages, they did 
not induce anti-T2 antibody production by rat lymph nodes. 
This was also true when the rat was the source of macro¬ 
phages and the rabbit the source of lymph node cells. 
These results were true in both in vivo and in vitro 
experiments. Finally, the finding by Cohen et al.56. 
of partial strain specificity in the conversion of non- 
immune mouse spleen cells to antibody-forming cells by 
•’immune" mouse RNA, makes species specificity seem not 
unreasonable 
. 
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CONCLUSIONS 
In conclusion, the basic ideas of the present experi¬ 
ments seem sound. The efficacy of the use of sensitized 
cells for the suppression of tumor growth has been well 
demonstrated in the past and has been confirmed by the 
relatively recent work of Bennett^ and of Alexander, et 
al.^4. The ability of "sensitized" RNA or RNA-containing 
complexes to transform isologous or homologous lymphoid 
cells to a state of antibody production or to a state of 
transplantation or homograft immunity is also well docu¬ 
mented. Also, recent work of Alexander, et al.^, has 
demonstrated that subcutaneous injection of RNA from immune 
animals into sarcoma-bearing rats can cause a temporary, 
and occasionally permanent, remission of the tumor. There¬ 
fore, attempts to produce tumor-sensitized isologous cells 
by the use of tumor-sensitized heterologous RNA should be 
successful if lymphoid cells could take up heterologous 
RNA: That this is not the case under the conditions of 
the present experiments is proven by the data, and this 
seems to be the best and most logical explanation of the 
present results. 
« 
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